| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.06 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.06 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.07 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.07 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.07 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | 0.091 | 0.07 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.08 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.052 | 0.08 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.048 | 0.08 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.056 | 0.08 |